Tuesday, July 12, 2016

BRIEF-Axsome Therapeutics previously reported net loss for year ended Dec. 31 understated

* Non-Cash $1.65 million premium associated with convertible

notes, should have been recorded directly to additional paid in

capital

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)